BIO ADVANCE

An Action Plan to Secure America’s Biotech Leadership
 

America pioneered the modern biotechnology industry and has led the world in developing lifesaving medicines for decades. Today, the U.S. biotech industry generates $3.2 trillion in economic output and directly employs more than 2.3 million Americans.

But America's biotech leadership is at risk.

From clinical research and contract services to manufacturing, supply chains, and data analysis, there is increased competition for U.S. companies, our economy, our health, and our security. That creates a growing risk that the United States could lose global prominence and fall behind in developing and manufacturing next-generation medicines.

The global biotech race is our generation's Space Race. America needs a plan to win.

That's why BIO developed BioAdvance: Securing America's Biotech Century - an action plan to secure America's position as the world's biotechnology powerhouse.

1. Coordinate a national strategy

   • Establish a White House Office of Biotechnology

2. Accelerate medical breakthroughs

   • Accelerate the path to first-in-human clinical studies

   • Modernize and streamline development at all stages in the United States

   • Improve access to clinical trials 

3. Build the future in America 

   • Ensure sustained support for academic and government biomedical research

   • Enable and incentivize U.S. contract manufacturing capacity and expertise 

   • Strengthen intellectual property protections and economic incentives that drive access to capital
      

Explore & Download BioAdvance
 

Watch: BIO President and CEO John F. Crowley explains what's at stake in the global biotech race - and how BioAdvance offers a path forward.